Scarica l'app Stockscreener
26.38
2.57%
0.66
Forte Biosciences Inc Azioni (FBRX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | 1.314 | - |
| Operating Expenses |
58.76%
18.38
|
11.58 | 16.12 | 7.351 | 8.629 |
| Operating Income/Loss |
58.76%
-18.38
|
-11.58 | -16.12 | -7.351 | -8.629 |
| Income/Loss From Continuing Operations Before Tax |
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
| Income/Loss From Continuing Operations After Tax |
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
Net Income/Loss
|
57.19%
-17.68
|
-11.25 | -15.66 | -7.155 | -8.392 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Earnings Per Share |
3.13%
-0.99
|
-0.96 | -1.37 | 3.18 | -4.54 |
| Diluted Earnings Per Share |
3.13%
-0.99
|
-0.96 | -1.37 | 3.18 | -4.54 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.82%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):